
You are here
AusPAR: Rivaroxaban
Related information
How to access a pdf or Word document
*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.
Australian Public Assessment Report
30 October 2019
AusPAR | |
---|---|
Active Ingredient | Rivaroxaban
|
Product Name | Xarelto
|
Sponsor | Bayer Australia Ltd
|
Submission Number | PM-2017-04819-1-3
|
Submission Type | Extension of indications new dosage
|
Decision | Approved
|
AusPAR Date | 22 October 2019
|
Publication Date | 30 October 2019 |